Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
The clinical trial is for men, with or without a diagnosis of prostate cancer, who are about to undergo a routine prostate-specific antigen (PSA) test.
The purpose of this study is to see if a PSA value derived from the Point of Care Rapid Test for is similar to the value obtained from a certified laboratory.
Participants who are visiting their physician to have their blood drawn to measure a PSA value will, within 1 hour of the blood test, also have a finger stick blood draw with a drop of blood placed on the measurement strip.
Participation is expected to last 1 day.
-Open to men above the age of 40 who are undergoing a blood test for PSA as part of standard of care.
Detailed eligibility reviewed when participant contacts the study team.
Upper East Side - Manhattan
Open to Enrollment
